Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrofuran SCHEMBL15993933 | 0.97 | ALDH1A1 (0.50) | ALDH1A1 | |
| Tetrahydrofuran SCHEMBL3369904 | 0.97 | ALDH1A1 (0.50) | ALDH1A1 | |
| Tetrahydrofuran SCHEMBL1896714 | 0.92 | ALDH1A1 (0.44) | ALDH1A1 | |
| Tetrahydrofuran SCHEMBL27895752 | 0.89 | ALDH1A1 (0.42) | ALDH1A1 | |
| Tetrahydrofuran SCHEMBL599386 | 0.89 | ALDH1A1 (0.42) | ALDH1A1 | |
| Hexane SCHEMBL6968999 | 0.87 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL971171 | 0.84 | TSHR (0.43) | — | |
| Dioxane SCHEMBL2947014 | 0.84 | TTR (0.43) | — | |
| Fluoride SCHEMBL6463523 | 0.84 | ADH1C (0.31) | — | |
| Dioxane SCHEMBL6069108 | 0.81 | TTR (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140194626-A1 | METHOD FOR PRODUCING AMIDO-ZINC HALIDE/ALKALI- METAL HALIDE COMPOUNDS | Rockwood Lithium GmbH (DE) | 2014-07-10 | — | — | US | claimed |
| WO-2021139795-A1 | METHOD FOR PREPARING PYRROLIDINYL UREA DERIVATIVE | 漳州片仔癀药业股份有限公司 | 2021-07-15 | — | — | WO | disclosed |
| CN-107223125-A | SGC stimulants | 铁木医药有限公司 | 2017-09-29 | — | — | CN | disclosed |
| CN-1556707-A | Methods of treating ophthalmic disorders using selective iNOS inhibitors | �ź㴫 | 2004-12-22 | — | — | CN | disclosed |
| CN-1556698-A | Neuroprotective treatment methods using selective iNOS inhibitors | �ź㴫 | 2004-12-22 | — | — | CN | disclosed |
| US-5760198-A | Process for preparation of 4\"-deoxyerythromycins A and B | ABBOTT LABORATORIES (US) | 1998-06-02 | — | — | US | disclosed |
| EP-0232875-B1 | METHOD FOR REMOVING LIPOPROTEINS USING AN ADSORBENT | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-05-08 | — | — | EP | disclosed |
| US-4814077-A | CELLULOSE OR AGAROSE SURFACE TREATED WITH AROMATIC AMINE | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-03-21 | — | — | US | disclosed |
| EP-0232875-A2 | Method for removing lipoproteins using an adsorbent | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-08-19 | — | — | EP | disclosed |
| US-4380629-A | Styryl-like compounds showing a color-developing and bleaching behavior with improved stability and prolonged lifetime | MATSUSHITA ELECTRIC INDUSTRIAL COMPANY, LIMITED (JP) | 1983-04-19 | — | — | US | disclosed |
| US-4115538-A | RADIOIMMUNOASSAY; ADENOSINE-3',5'-CYCLIC MONOPHOSPHATE, GUANOSINE-3',5'-CYCLIC MONOPHOSPHATE | YAMASU SHOYU KABUSHIKI KAISHA (JP) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194626-A1 | METHOD FOR PRODUCING AMIDO-ZINC HALIDE/ALKALI- METAL HALIDE COMPOUNDS | ZRANB2, ZKSCAN2, SLC39A11 | ALDH1A1 3729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.